MEDRAD has received FDA clearance for use of its Continuum MR infusion system in MR environments up to and including 3.0T. The new FDA clearance enables clinicians working in the latest 3.0T environments to infuse medications, sedatives and other drugs while benefiting from Continuum’s dose enhancements.
MEDRAD had began testing in 3.0T, and Continuum is now cleared to provide guidance for safety and performance in that environment. MR accessory equipment must meet safety standards and perform without interfering with the quality of medical images. Tests for attraction, homogeneity, artifact and static magnetic field are designed to ensure that the system meets or exceeds these requirements, and the results confirm that it does.
In the most recent enhancement to Continuum, a greater selection of drug-specific units of measurement was added, increasing the number of drugs that can be infused. It also helps prevent programming errors by reducing the confusion of manual conversions.